High GLUT-1 levels are associated with increased [18F]FDG uptake in human tumors and are also considered a marker of hypoxia, as tumor blood vessels often fail to meet local metabolic needs [7] (Fig. 3). This evidence concerns the gene SLC2A1 and neoplasm.